… of anticoagulant effect. Although there is no specific antidote to antagonise the anticoagulant
… is usually sufficient to reverse any excessive anticoagulant activity. In case of potential …

… its orally active prodrug,dabigatran etexilate.This study set out to determine the molecular
potency and anticoagulant efficacy of dabigatran and its prodrug dabigatran etexilate.This was …

… dabigatran anticoagulant activity and liquid chromatography-tandem mass spectrometry (LC-MS/MS)
to measure dabigatran … dabigatran etexilate is unknown. Long-term stability of the …

… assess the anticoagulant effects of dabigatran etexilate (DE). … the value of monitoring
dabigatran levels and adjusting the … could be used to assess its anticoagulant activity. Despite the …

… HMW Ex vivo anticoagulant activity of BIBR953ZW, a novel synthetic direct thrombin inhibitor
and of its prodrug BIBR1048 MS in different animal species. 18th Cong Int Soc Thromb …

… dabigatran etexilate to a parenteral anticoagulant should wait for 24 hours after the last dose
before commencing the parenteral anticoagulant.[… anticoagulants to dabigatran etexilate.[6] …

… judgments for dabigatran etexilate usage has been … dabigatran etexilate has only been
based on the correlation between the anticoagulant activity in each test and dabigatran etexilate …

… clotting time (ECT) is observed at dabigatran concentrations ranging from 0.1 up to 4.6 μM,
… for anticoagulant activity. The thrombin time (TT) assay is extremely sensitive to dabigatran’s …

… - a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays
and reversal of anticoagulant activity. Thromb Haemost 2010;103:1116-1127. Used with …

… 1b), which showed strong and long-lasting anticoagulant effects after oral administration in
… the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilate, on …